About
NeuroQore develops neuromodulation treatments targeting treatment-resistant major depressive disorder and suicidality, collaborating with research institutions to create innovative therapies with faster onset and fewer side effects than existing standards.
Explore NeuroQore, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.